Neogenomics (NEO) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $536.5 million.
- Neogenomics' Total Liabilities fell 2679.91% to $536.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $536.5 million, marking a year-over-year decrease of 2679.91%. This contributed to the annual value of $735.7 million for FY2024, which is 53.98% down from last year.
- According to the latest figures from Q3 2025, Neogenomics' Total Liabilities is $536.5 million, which was down 2679.91% from $539.9 million recorded in Q2 2025.
- Neogenomics' Total Liabilities' 5-year high stood at $769.1 million during Q3 2021, with a 5-year trough of $536.5 million in Q3 2025.
- Its 5-year average for Total Liabilities is $713.9 million, with a median of $735.7 million in 2024.
- In the last 5 years, Neogenomics' Total Liabilities soared by 18639.42% in 2021 and then tumbled by 2679.91% in 2025.
- Quarter analysis of 5 years shows Neogenomics' Total Liabilities stood at $761.5 million in 2021, then decreased by 2.56% to $742.0 million in 2022, then dropped by 0.31% to $739.7 million in 2023, then dropped by 0.54% to $735.7 million in 2024, then fell by 27.08% to $536.5 million in 2025.
- Its last three reported values are $536.5 million in Q3 2025, $539.9 million for Q2 2025, and $713.2 million during Q1 2025.